International Journal of Technology Assessment in Health Care

Article	Citations
Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations	105
Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders	37
Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward	36
Principles for deliberative processes in health technology assessment	29
Real-world evidence use in assessments of cancer drugs by NICE	28
Patient and public involvement in health technology assessment: update of a systematic review of international experiences	27
The effects of mobile apps on stress, anxiety, and depression: overview of systematic reviews	25
Health technology assessment for digital technologies that manage chronic disease: a systematic review	25
The broader societal impacts of COVID-19 and the growing importance of capturing these in health economic analyses	24
Development of a checklist to guide equity considerations in health technology assessment	19
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal	18
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements	15
Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story	13
Mind the evidence gap: the use of patient-based evidence to create “complete HTA” in the twenty-first century	13
Early economic evaluation to guide the development of a spectroscopic liquid biopsy for the detection of brain cancer	13
Addressing the challenges of implementing a Health Technology Assessment Policy Framework in South Africa	13
Considering and communicating uncertainty in health technology assessment	12
On the integration of early health technology assessment in the innovation process: reflections from five stakeholders	12
Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach	12
An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency	12
Economic evaluation guidelines in low- and middle-income countries: a systematic review	12
Beyond the numbers: a critique of quantitative multi-criteria decision analysis	12
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements	12
A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic	11
Systematic review search methods evaluated using the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses and the Risk Of Bias In Systematic reviews tool	11

Model for ASsessing the value of Artificial Intelligence in medical imaging (MAS-AI)	11
Environmental impact assessment in health technology assessment: principles, approaches, and challenges	11
Exploring the identification, validation, and categorization of the cost and benefits of criminal justice in mental health: the PECUNIA project	10
COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection	10
Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration	10
Incorporating environmental and sustainability considerations into health technology assessment and clinical and public health guidelines: a scoping review	10
Evaluation of the impact of patient input in health technology assessments at NICE	10
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force	10
PP424 Piloting A Comprehensive Search For eHealth Definitions In The Grey Literature: Preliminary Results From A Systematic Scoping Review	9
Examining the impact of different country processes for appraising rare disease treatments: a case study analysis	9
The NICE MEDLINE and Embase (Ovid) health apps search filters: development of validated filters to retrieve evidence about health apps	9
Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices	9
How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations	9
The estimation of health state utility values in rare diseases: overview of existing techniques	8
Can multi-criteria decision analysis (MCDA) be implemented into real-world drug decision-making processes? A Canadian provincial experience	8
A review of HTA guidelines on societal and novel value elements	8
Value of mesenchymal stem cell therapy for patients with septic shock: an early health economic evaluation	8
Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: implications for cancer control program in India	8
Patient involvement in relative effectiveness assessments in the European Network for Health Technology Assessment	8
Economic impact of the use of the National Surgical Quality Improvement Program	8
Implementation of a new Digi-HTA process for digital health technologies in Finland	7
On the role of cost-effectiveness thresholds in healthcare priority setting	7
Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis	7
Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation	7
Determinants of Managed Entry Agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countries	7
Application of a health technology assessment framework to digital health technologies that manage chronic disease: a systematic review	7
A model-based study to estimate the health and economic impact of health technology assessment in Thailand	7
Developing recommendations for the diagnosis and treatment of Lyme disease: the role of the patient's perspective in a controversial environment	7
Assessing the capacity of Ghana to introduce health technology assessment: a systematic review of economic evaluations conducted in Ghana	6
Health Technology Assessment in Support of National Health Insurance in South Africa	6
Peer review of searches for studies for health technology assessments, systematic reviews, and other evidence syntheses	6
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment	6
Addressing uncertainty in relative effectiveness assessments by HTA organizations	6
A toolkit of methods of development-focused health technology assessment	6
A framework for action to improve patient and public involvement in health technology assessment	6
Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?	6
Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations	6
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework	6
Evaluating physicians’ perspectives on the efficiency and effectiveness of the electronic prescribing system	6
Relevance of the newly defined Health Technology Assessment: COVID-19 and beyond	5
Health technology assessment applied to emergency preparedness: a new perspective	5
Prioritizing critical-care resources in response to COVID-19: lessons from the development of Thailand's Triage protocol	5
Technology assessment framework for precision health applications	5
How does HTA addresses current social expectations? An international survey	5
Patient and public involvement in Health Technology Assessment: a new dawn?	5
Evaluation of patient involvement strategies in health technology assessment in Spain: the viewpoint of HTA researchers	5
Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe	5
Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries	5
Physician–patient shared decision making, patient satisfaction, and adoption of new health technology in China	5
Stakeholder preferences for attributes of digital health technologies to consider in health service funding	5

Postlaunch evidence-generation studies for medical devices in Spain: the RedETS approach to integrate real-world evidence into decision making	4
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group	4
Quality of health economic evaluations submitted to the Italian Medicines Agency: current state and future actions	4
Qualitative comparative analysis of health economic evaluation guidelines for health technology assessment in European countries	4
Collaboration applications for mixed home care — A systematic review of evaluations and outcomes	4
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities	4
Integration of ethical considerations into HTA reports: an analysis of integration levels using a systematic review	4
Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot	4
Using discrete-choice experiments to elicit preferences for digital wearable health technology for self-management of chronic kidney disease	4
Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health	4
Values, principles, strategies, and frameworks underlying patient and public involvement in health technology assessment and guideline development: a scoping review	4
Cost-effectiveness analysis of magnetic resonance-guided focused ultrasound ablation for palliation of refractory painful bone metastases	4
Health technology assessment: A matter of facts and values	4
Evaluating traditional and complementary medicines: Where do we go from here?	4
Development of an international template to support patient submissions in Health Technology Assessments	4
Evidence-based searching for health technology assessment: keeping up to date with SuRe Info	3
Strengthening patient outcome evidence in health technology assessment: a coproduction approach	3
The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies	3
Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future	3
Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review	3
Systems thinking in health technology assessment: a scoping review	3
Integrating Early Economic Evaluation into Target Product Profile development for medical tests: advantages and potential applications	3
Development of a decisional flowchart for meaningful patient involvement in Health Technology Assessment	3
Developing an agency's position with respect to patient involvement in health technology assessment: the importance of the organizational culture	3
Redefining Health Technology Assessment: A Comment on “The New Definition of Health Technology Assessment: A Milestone in International Collaboration”	3
A framework for local-level economic evaluation to inform implementation decisions: health service interventions to prevent hospital-acquired hypoglycemia	3
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”	3
Establishment and implementation of hospital-based health technology assessment at King Hussein Cancer Center: can our model be an example?	3
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases	3
Assessment of technical errors and validation processes in economic models submitted by the company for NICE technology appraisals	3
Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of “Failed” R&D Efforts	3
Lessons from the vaginal mesh scandal: enhancing the patient-centric approach to informed consent for medical device implantation	3
The development process of economic evaluation guidelines in low- and middle-income countries: a systematic review	3
Overview of information retrieval in a hospital-based health technology assessment center in a Swedish region	3
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks	3
Disruptive technologies in health care disenchanted: a systematic review of concepts and examples	3
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review	3
Pilot approach to analyzing patient and citizen involvement in health technology assessment in four diverse low- and middle-income countries	3
Creating enriched training sets of eligible studies for large systematic reviews: the utility of PubMed's Best Match algorithm	3
Postlaunch evidence generation practices among health technology assessment bodies in Europe	3
A model to assess the impact of digital technologies on the health-related quality of life	3
Core competencies for ethics experts in health technology assessment	3
Topic selection process in health technology assessment agencies around the world: a systematic review	3
Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults	2
A HTA of what? Reframing through including patient perspectives in health technology assessment processes	2
Adherence to country-specific guidelines among economic evaluations undertaken in three high-income and middle-income countries: a systematic review	2
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework – Corrigendum	2
Understanding innovation of health technology assessment methods: the IHTAM framework	2
Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature	2
Test–retest reliability of the Cost for Patients Questionnaire	2
Moving from intervention management to disease management: a qualitative study exploring a systems approach to health technology assessment in Canada	2
Patient and caregiver engagement in the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System (HCHSS) process	2
Demonstrating the influence of HTA: INAHTA member stories of HTA impact	2
Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body	2
Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3	2
Information specialist collaboration in Europe: collaborative methods, processes, and infrastructure through EUnetHTA	2
The cost of metastatic prostate cancer using time-driven activity-based costing	2
Patient and citizen participation at the organizational level in health technology assessment: an exploratory study in five jurisdictions	2
Hospital-based health technology assessment in Brazil: current experiences and challenges	2
Early access schemes for innovative health technologies: the views of international stakeholders	2
Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach	2
Valuing Alzheimer's disease drugs: a health technology assessment perspective on outcomes	2
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis	2
Survey investigating the knowledge and awareness of payers and patient advocacy groups about the health technology assessment process in Lebanon	2
Economic evaluation of genomic/genetic tests: a review and future directions	2
Exploring facilitators and barriers to introducing health technology assessment: a systematic review	2
Promoting health economic evaluation studies in the AYUSH system of medicine: the need of the hour	2
Benchmarking health technology assessment agencies—methodological challenges and recommendations	2
Projecting effectiveness after ending a randomized controlled trial: a two-state Markov microsimulation model	2
A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment	2
Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project	2
Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets	2
Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System: the cefiderocol example	2
PP40 Health Apps To Manage Depression: Can We Separate The Grain From The Chaff? EvalDepApps Project	2
Expanding health technology assessment towards broader value: Ireland as a case study	2
Disinvestment in healthcare: a scoping review of systematic reviews	2
PD20 Real-World Evidence To Support Single Arm Trials Of Oncology Interventions: Necessity or ‘NICE’ (National Institute for Health and Care Excellence) to Have?	2
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling	2
A different animal but the same beast? Using development-focused health technology assessment to define the value proposition of medical technologies	2
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies	2

PP162 Digital Medication Health Service Platforms Of Pharmaceutical Companies As Novel Sources Of Real-World Data For Health Technology Assessment	2
Evaluation of precision medicine assessment reports of the Belgian healthcare payer to inform reimbursement decisions	2
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics	2
The contribution of French patient and consumer groups to health technology assessments over a 2-year period: an observational retrospective study	2
Do France, Germany, and Italy agree on the added therapeutic value of medicines?	2
Glycated hemoglobin as a surrogate for evaluating the effectiveness of drugs in diabetes mellitus trials: a systematic review and trial-level meta-analysis	2
The role of ethical analysis in conducting a health technology assessment of medical treatments for gender dysphoria	2
A review of implementation frameworks to operationalize health technology assessment recommendations for medical technologies in the Singapore setting	2
Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan	1
OP223 A Semi-Automated Process To Monitor The Clinical Development And Regulatory Approval Pathway Of Innovative Medicines	1
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations	1
Novel approach to decision making for orphan drugs	1
Mapping horizon scanning systems for medical devices: similarities, differences, and lessons learned	1
PP28 Is My Medicine Suitable For An Outcomes Based Agreement? The Feasibility Conundrum	1
Genuine policy learning is fundamental: the journey of the United Arab Emirates toward the establishment of health technology assessment	1
Community engagement in Health Technology Assessment and beyond: from guests in the process to hosts	1
Involvement of information specialists and statisticians in systematic reviews	1
OP28 Health Technology Assessment: A Situation Analysis Of Zimbabwe	1
Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective	1
OP283 A Pipeline Analysis Of Advanced Therapy Medicinal Products (ATMPs) In Late-Stage Clinical Development	1
OP87 Value From A Multi-stakeholder Perspective: A Framework To Assess Digital Health Solutions For Improving Chronic Disease Management	1
Neglected impacts of patient decision-making associated with genetic testing	1
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities	1
Economic feasibility of a novel tool to assist extubation decision-making: an early health economic modeling	1
PP138 Current Status Of Healthcare Decision Making And Future Perspective Of The Health Technology Assessment Implementation Roadmap In Turkey	1
Best practice considerations on the assessment of robotic assisted surgical systems: results from an international consensus expert panel	1
PP43 Impact Of The COVID-19 Pandemic In The Brazilian National Committee for Health Technology Incorporation (Conitec) Recommendation Process	1
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement	1
PP261 Development Of A Mapping Algorithm To Predict SF-6D Values In People With Drug-Resistant Focal Onset Seizures	1
THE EXTENT AND QUALITY OF QUALITATIVE EVIDENCE INCLUDED IN HEALTH TECHNOLOGY ASSESSMENTS: A REVIEW OF SUBMISSIONS TO NICE AND CADTH	1
PP553 Study On The Utilization Of Medical Resources In Patients With Malignant Tumors in China	1
A voice to be heard: patient and public involvement in health technology assessment and clinical practice guidelines in Malaysia	1
Informing decision makers about public preferences for different modalities of cancer treatment in the Rhône–Alps region in France	1
OP218 Searching Preprint Repositories For COVID-19 Therapeutics Using A Semi-Automated Text-Mining Tool	1
A decision-support tool for funding health innovations at a tertiary academic medical center	1
OP535 Cost-Effectiveness Of Internet-Based HIV Screening In Men Who Have Sex With Men in Vancouver, British Columbia, Canada	1
Adjustment of publication bias using a cumulative meta-analytic framework	1
Assessing progression of health technology assessment implementation in Asia: a balanced scorecard for cross comparison of selected countries in Asia	1
PP90 Effectiveness Of Music Therapy For Autism Spectrum Disorder, Dementia, Depression, Insomnia, And Schizophrenia	1
PP434 Quality Of Studies Submitted To Support Requests For Medical Devices And Equipment Incorporation In A Teaching Hospital	1
OP01 Convergent Validity Between Discrete Choice Experiment And Other Stated Preference Methods: A Multistudy Comparison	1
Patients’ knowledge and awareness about patient support programs: a cross-sectional study on Lebanese adults with chronic diseases	1
The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries’ past health technology assessments	1
PP70 Enhancing HTA Processes In The Maltese System For Introducing New Medicines	1
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect	1
Identification and selection of health technologies for assessment by agencies in support of reimbursement decisions in Latin America	1
PP290 Ongoing Swedish Initiatives To Improve The Potential For Real World Data Assessment Of Medical Devices	1
Patient Perspectives: An Integral Part of Health Technology Assessment Methodology	1
Beyond clinical and cost-effectiveness: The contribution of qualitative research to health technology assessment	1
Using social media research in health technology assessment: stakeholder perspectives and scoping review	1
OP95 A Systematic Review Of The Cost And Cost Effectiveness Of Immunoglobulin Treatment In Patients With Hematological Malignancies	1
Value-based payment for high-cost treatments in Singapore: a qualitative study of stakeholders’ perspectives	1
A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value	1
OP520 Evaluating Long-Term Survival From Clinical Trials: Does Real-World Evidence Change the Paradigm?	1
EUnetHTA’s contribution to the new legal framework for health technology assessment cooperation in Europe	1
Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews	1
EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness	1
European collaboration on health technology assessment: looking backward and forward	1
Response to “UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP”	1
Rapid qualitative evidence syntheses (rQES) in health technology assessment: experiences, challenges, and lessons	1
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data	1
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data	1
Methods and criteria for the assessment of orphan drugs: a scoping review	1
International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market	1
Fit for the future? Status of health-related quality of life research in South Africa	1
PP265 Application Of A Case-Mix Method For Medical Consumables Management In Anhui Province, China Using Healthcare Big Data	1
Clinical effectiveness reporting of novel cancer drugs in the context of non-proportional hazards: a review of nice single technology appraisals	1
Manufacturers’ perceptions of the decision-making process for new drug reimbursement in South Korea	1
Using INTEGRATE-HTA for the assessment of videorasterstereography in idiopathic scoliosis	1
The rationale and design of public involvement in health-funding decision making: focus groups with the Canadian public	1
Design of a multiple criteria decision analysis framework for prioritizing high-impact health technologies in a regional health service	1
Opportunities to improve reporting of rapid response in health technology assessment	1
PP228 Strategy For Including Information On The Research Priorities Of Patients And Experts In Health Technology Assessment Reports	1
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders	1
PP531 Quality Of Life Of Patients With Long-Chain Fatty Acid Oxidation Disorders Before And During Treatment With Triheptanoin	1
A Technical Review of the ISPOR Presentations Database Identified Issues in the Search Interface and Areas for Future Development	1
Emerging healthcare interventions: Patient-Centered Outcomes Research Institute’s programmatic initiative	1
PP385 Using Common Data Models And Data Networks For Evidence Generation In Health Technology Assessment	1
Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets	1
Response to redefining health technology assessment: a comment on “the new definition of health technology assessment: a milestone in international collaboration”	1
Mecanismos de identificación y priorización de las tecnologías sanitarias a ser evaluadas por las Agencias de ETESA para decisiones de cobertura en Latino America	1
Synthesizing quantitative and qualitative information on multiple comparisons of health interventions to facilitate knowledge transfer: an example from an EUnetHTA multi-HTA	1
Assessing the early impact of a hospital-based health technology assessment program, smart innovation	1
Impact of rarity on Canadian oncology health technology assessment and funding	1
PP414 Improving The Accessibility Of Scottish Medicines Consortium Advice	1
PD45 Paying For Digital Health: What Evidence Is Needed?	1
Using early health economic modeling to inform medical innovation development: a soft robotic sock in poststroke patients in Singapore	1
Access to medicines in Turkey: Evaluation of the process of medicines brought from abroad	1
OP615 Implementing EUnetHTA Products: The Implementation Experiences In Italy	0
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis	0
PP262 PapSEEK: Liquid Biopsy For Endometrial And Ovarian Cancer Screening	0
OP366 Characterizing The Population At Risk Of Chronic Obstructive Pulmonary Disease In China Using A Real-World Population Survey	0
OP123 The Use Of Surrogate Outcomes In National Institute For Health And Care Excellence (NICE) Highly Specialised Technology Evaluations: A Review Of Published Guidance	0
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders – Erratum	0
A collaborative pilot on current awareness alerts for disinvestment and horizon scanning	0